Sign In

Tom McCarthy

Founder and CEO, Molecule 2 Medicine

Tom McCarthy is a distinguished professional with a strong background in the pharmaceutical and biotechnology industry.

He is the Founder, CEO, and Director at Molecule 2 Medicine, showcasing his entrepreneurial spirit and leadership skills.

With a history of founding and chairing multiple organizations like Grey Wolf Therapeutics, Pathios Therapeutics, and Orbit Discovery, Tom has demonstrated his strategic vision and innovative approach to business.

His experience as a Venture Partner at Brandon Capital Partners and as a Non-Executive Director at Kea Therapeutics and Trigemina, Inc. highlights his expertise in investment and governance.

Tom McCarthy has also held significant executive roles, serving as the President, CEO, and Managing Director at Spinifex Pharmaceuticals Inc and Spinifex Pharmaceuticals Pty Ltd, and as the VP of Drug Development at Starpharma Holdings Limited.

Throughout his career, Tom has been instrumental in driving growth, fostering collaborations, and bringing breakthrough therapies to the market.

His diverse skill set encompasses business development, strategic planning, drug development, and corporate leadership.

Tom McCarthy's contributions to the pharmaceutical and biotechnology sectors have been pivotal in advancing healthcare and improving patient outcomes.

He continues to be a prominent figure in the industry, leveraging his experience and expertise to make a positive impact.

Tom McCarthy
Add to my network

Location

Oxford, United Kingdom